ZAMBELLI ALBERTO

Belloni, S., Tiberio, P., De Sanctis, R., Magon, A., Santoro, A., Zambelli, A., et al. (2024). Corrigendum to “Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis” [Crit. Rev. Oncol./Hematol. 204 (2024) 104527](S1040842824002701)(10.1016/j.critrevonc.2024.104527) [Altro] [10.1016/j.critrevonc.2024.104550]. Detail

Cazzaniga, M., Pronzato, P., Amoroso, D., Bernardo, A., Biganzoli, L., Bisagni, G., et al. (2024). Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study. CANCERS, 16(1) [10.3390/cancers16010117]. Detail

Benvenuti, C., Grinda, T., Rassy, E., Dixon-Douglas, J., Ribeiro, J., Zambelli, A., et al. (2024). Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer – A Clinical Review. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 25(12), 1517-1537 [10.1007/s11864-024-01259-4]. Detail

Gelardi, F., Cavinato, L., De Sanctis, R., Ninatti, G., Tiberio, P., Rodari, M., et al. (2024). The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [18F]FDG PET: Preliminary Results from a Prospective Cohort. DIAGNOSTICS, 14(20) [10.3390/diagnostics14202312]. Detail

Gori, S., De Rose, F., Ferro, A., Fabi, A., Angiolini, C., Azzarello, G., et al. (2024). Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project. CANCER TREATMENT REVIEWS, 131(December 2024) [10.1016/j.ctrv.2024.102832]. Detail